Have a feature idea you'd love to see implemented?
Let us know!
PLUR Pluri Inc
Price (delayed)
$4.7
Market cap
$26.13M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.12
Enterprise value
$53.44M
Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented
Highlights
Pluri's revenue has soared by 135% YoY and by 83% from the previous quarter
The gross profit has soared by 91% YoY and by 45% from the previous quarter
Pluri's EPS has increased by 26% YoY but it has decreased by 3.3% QoQ
The net income is up by 20% year-on-year but it has declined by 4.4% since the previous quarter
The equity has plunged by 159% YoY
The quick ratio has contracted by 28% YoY and by 16% from the previous quarter
Key stats
What are the main financial stats of PLUR
Market
Valuations
Earnings
Shares outstanding
5.56M
Market cap
$26.13M
Enterprise value
$53.44M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
42.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
89.36
Revenue
$598,000
EBIT
-$22.62M
EBITDA
-$22.37M
Free cash flow
-$16.66M
Per share
Balance sheet
Liquidity
EPS
-$4.12
Free cash flow per share
-$3.05
Book value per share
-$0.97
Revenue per share
$0.11
TBVPS
$6.49
Total assets
$35.44M
Total liabilities
$35.51M
Debt
$30.88M
Equity
-$5.28M
Working capital
$22.45M
Debt to equity
-5.84
Current ratio
5.9
Quick ratio
5.68
Net debt/EBITDA
-1.22
Margins
Efficiency
Dividend
EBITDA margin
-3,740.6%
Gross margin
78.3%
Net margin
-3,647%
Operating margin
-3,675.4%
Return on assets
-57%
Return on equity
N/A
Return on invested capital
-39%
Return on capital employed
-73.3%
Return on sales
-3,782.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PLUR stock price
How has the Pluri stock price performed over time
Intraday
-7.11%
1 week
-13.76%
1 month
-1.05%
1 year
1.51%
YTD
1.29%
QTD
-22.31%
Financial performance
How have Pluri's revenue and profit performed over time
Revenue
$598,000
Gross profit
$468,000
Operating income
-$21.98M
Net income
-$21.81M
Gross margin
78.3%
Net margin
-3,647%
Pluri's revenue has soared by 135% YoY and by 83% from the previous quarter
The gross profit has soared by 91% YoY and by 45% from the previous quarter
PLUR's net margin has surged by 66% year-on-year and by 43% since the previous quarter
Pluri's operating margin has surged by 64% YoY and by 46% QoQ
Growth
What is Pluri's growth rate over time
Valuation
What is Pluri stock price valuation
P/E
N/A
P/B
N/A
P/S
42.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
89.36
Pluri's EPS has increased by 26% YoY but it has decreased by 3.3% QoQ
The equity has plunged by 159% YoY
Pluri's revenue has soared by 135% YoY and by 83% from the previous quarter
PLUR's P/S is 45% below its last 4 quarters average of 78.6
Efficiency
How efficient is Pluri business performance
Pluri's return on sales has surged by 62% YoY and by 43% QoQ
Pluri's return on assets has decreased by 11% YoY and by 10% QoQ
PLUR's return on invested capital is down by 9% year-on-year and by 7% since the previous quarter
Dividends
What is PLUR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PLUR.
Financial health
How did Pluri financials performed over time
The quick ratio has contracted by 28% YoY and by 16% from the previous quarter
The current ratio has declined by 28% year-on-year and by 15% since the previous quarter
The equity has plunged by 159% YoY
The debt to equity has dropped by 102% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.